Italy
· Delayed Price · Currency is EUR Madrigal Pharmaceuticals Statistics
Total Valuation
BIT:1MDGL has a market cap or net worth of EUR 10.12 billion. The enterprise value is 9.58 billion.
| Market Cap | 10.12B |
| Enterprise Value | 9.58B |
Important Dates
The next confirmed earnings date is Wednesday, May 6, 2026.
| Earnings Date | May 6, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 22.94M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +5.46% |
| Shares Change (QoQ) | +1.54% |
| Owned by Insiders (%) | 8.48% |
| Owned by Institutions (%) | 70.39% |
| Float | 12.49M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 12.40 |
| PB Ratio | 19.72 |
| P/TBV Ratio | 19.96 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -39.01 |
| EV / Sales | 11.70 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -59.19 |
Financial Position
The company has a current ratio of 4.01, with a Debt / Equity ratio of 0.58.
| Current Ratio | 4.01 |
| Quick Ratio | 3.60 |
| Debt / Equity | 0.58 |
| Debt / EBITDA | n/a |
| Debt / FCF | -1.83 |
| Interest Coverage | -13.45 |
Financial Efficiency
Return on equity (ROE) is -42.49% and return on invested capital (ROIC) is -20.56%.
| Return on Equity (ROE) | -42.49% |
| Return on Assets (ROA) | -16.30% |
| Return on Invested Capital (ROIC) | -20.56% |
| Return on Capital Employed (ROCE) | -31.61% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | 892,100 |
| Profits Per Employee | -268,340 |
| Employee Count | 915 |
| Asset Turnover | 0.83 |
| Inventory Turnover | 1.03 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 409.91 |
| 200-Day Moving Average | 397.64 |
| Relative Strength Index (RSI) | 55.88 |
| Average Volume (20 Days) | 0 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 11.21 |
Income Statement
In the last 12 months, BIT:1MDGL had revenue of EUR 816.27 million and -245.53 million in losses. Loss per share was -10.94.
| Revenue | 816.27M |
| Gross Profit | 768.45M |
| Operating Income | -255.59M |
| Pretax Income | -245.53M |
| Net Income | -245.53M |
| EBITDA | -254.31M |
| EBIT | -255.59M |
| Loss Per Share | -10.94 |
Balance Sheet
The company has 837.70 million in cash and 296.08 million in debt, giving a net cash position of 541.62 million.
| Cash & Cash Equivalents | 837.70M |
| Total Debt | 296.08M |
| Net Cash | 541.62M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 513.31M |
| Book Value Per Share | 22.47 |
| Working Capital | 796.75M |
Cash Flow
In the last 12 months, operating cash flow was -161.44 million and capital expenditures -397,744, giving a free cash flow of -161.84 million.
| Operating Cash Flow | -161.44M |
| Capital Expenditures | -397,744 |
| Depreciation & Amortization | 1.29M |
| Net Borrowing | 194.86M |
| Free Cash Flow | -161.84M |
| FCF Per Share | n/a |
Margins
Gross margin is 94.14%, with operating and profit margins of -31.31% and -30.08%.
| Gross Margin | 94.14% |
| Operating Margin | -31.31% |
| Pretax Margin | -30.08% |
| Profit Margin | -30.08% |
| EBITDA Margin | -31.16% |
| EBIT Margin | -31.31% |
| FCF Margin | n/a |
Dividends & Yields
BIT:1MDGL does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -5.46% |
| Shareholder Yield | -5.46% |
| Earnings Yield | -2.43% |
| FCF Yield | -1.60% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
BIT:1MDGL has an Altman Z-Score of 6.26 and a Piotroski F-Score of 2.
| Altman Z-Score | 6.26 |
| Piotroski F-Score | 2 |